OBGYN Flashcards

1
Q

CIN types

A

CIN 1: mild, lower 1/3
CIN 2: moderate, lower 2/3
CIN 3: severe, over 2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gardasil vaccine

A

Recommended at age 11-12 (from Hannah’s quizlet)

Age 9-14: 2-dose - 0 months and 6-12 months OR 3-dose - 0, 2, 6 months
Age 15-45: 3-dose (0, 2, 6 months)
(from Epperly’s slides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cervical cancer screening

A

Start at age 21
Pap every 3 years until 30
Pap & HPV every 5 years from 30-65 OR pap only every 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When to stop screening for cervical cancer?

A

65+
No hx of moderate or severe dysplasia
3 negative paps in a row

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pap smear results

A

ASCUS (undetermined significance)
ASCH (cannot exclude high-grade lesion)
LGSIL (low-grade squamous intraepithelial, corresponds to CIN 1)
HGSIL (high-grade squamous intraepithelial, corresponds to CIN 2/3)
AGC (atypical glandular cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of ASCUS

A

Repeat paps every 6 months until normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Next step for LGSIL and HGSIL

A

Colposcopy and biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment of CIN 1

A

Expectant management
2 paps every 6 months or pap & HPV test every 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of CIN 2 or 3

A

Surgical procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HPV strains most correlated with cervical cancer

A

16, 18, 45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

S/S of cervical cancer

A

Abnormal vaginal bleeding
*Postcoital bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of cervical cancer

A

Radical hysterectomy and lymphadenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common gyn malignancy

A

Endometrial cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk factors for endometrial cancer

A

Unopposed estrogen
Obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risk reduction for endometrial cancer

A

Combo OCP use
Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

S/S of endometrial cancer

A

Abnormal uterine bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MCC of endometrial cancer

A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnosis of endometrial cancer

A

US first
Biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of endometrial cancer

A

Total hysterectomy with bilateral salpingo-oopherectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Lactational amenorrhea

A

Exclusive breastfeeding leading to amenorrhea and contraception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MOA of OCP

A

Ovulation suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benefits of combination OCP use

A

Reduced endometrial and ovarian cancer
Increase bone mass
Acne improvements
Dysmenorrhea improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

SE of combo OCP use

A

VTE
Cervical dysplasia
Breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CI of combo OCP use

A

Migraines with aura
Smokers over 35
Hx of VTE
Hx of breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

CI for progestin only OCP use

A

breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Paragard characteristics (Copper IUD)

A

Every 10 years
Non-hormonal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Nexplanon characteristics (implant)

A

Every 3 years
Progesterone only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Depo characteristics (injection)

A

Every 3 months
Progesterone only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

IUD characteristics

A

Progesterone only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cystocele

A

Protrusion of the bladder into anterior vagina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

S/S of pelvic organ prolapse

A

Fullness and pressure (“falling out” sensation)
Pelvic pain
Urinary incontinence
Straining

worse with prolonged standing
better with lying down.

32
Q

Uterine prolapse

A

Descent of uterus into the vagina

33
Q

grading for uterine prolapse

A

grade 0: no descent
grade 1: descent into upper 2/3 of vagina
grade 2: cervix approaches introitus
grade 3: cervix outside introitus
grade 4: uterus outside vagina

34
Q

Rectocele

A

Protrusion of rectum into posterior vagina

35
Q

Enterocele

A

pouch of douglas small bowel herniating into upper vagina.

36
Q

Treatment of pelvic organ prolapse

A

Pessary
Kegels
Surgical treatment (hysterectomy)
Estrogen for vaginal atrophy

37
Q

Dysmenorrhea

A

Painful menstruation

38
Q

Etiology of dysmenorrhea

A
  • primary = increased prostaglandins
  • secondary = pelvis/uterus pathology (endometriosis, PID, ect. )
39
Q

Treatment of dysmenorrhea

A

NSAIDs
Hormonal contraceptives

if unresponsive to 3 cycles of initial therapy, consider laparoscopy.

40
Q

When does PMS/PMDD tend to occur

A

1-2 weeks prior to menses lasting until 2nd/3rd day of menses

41
Q

S/S of PMS and PMDD

A

HA
Fatigue
Breast tenderness
Bloating
Abdominal pain
Mood swings
Irritability

42
Q

PMS vs PMDD

A

PMS: cluster of physical, behavioral and mood changes with cyclical occurrence during the luteal phase of menses
PMDD: Severe PMS presenting with clear functional impairment and predominant psych symptoms

43
Q

Treatment of PMS/PMDD

A

Mild: behavioral modifications and symptomatic tx
Severe: SSRIs and OCPs

44
Q

Menorrhagia

A

Heavy bleeding

45
Q

Hypomenorrhea

A

Light bleeding

46
Q

Metrorrhagia

A

Bleeding between normal menses

47
Q

Polymenorrhea

A

Menses occurring too frequently

48
Q

Menometrorrhagia

A

Bleeding with irregular intervals and amount

49
Q

Oligomenorrhea

A

Menses occurring too infrequently

50
Q

What is a common underlying cause of dysfunctional uterine bleedig

A
  • anovulation: ovaries producing estrogen but not ovulation (corpus luteum)
  • unopposed estrogen leads to endometrial growth and shedding.
51
Q

what physical exam findings may be present in dysfunctional uterine bleeding

A
  • abnormal bleeding with normal exam
  • mass or enlarged irregular uterus (leiomyoma)
  • symmetrically enlarged uterus (adenomysosis or endometrial cancer)
52
Q

Evaluation of dysfunctional uterine bleeding (DUB)

A

Pelvic US
Endometrial biopsy
Hysteroscopy

53
Q

when is endometrial biopsy warranted in dysfunctional uterine bleeding

A

to rule out cancer in all women >35 with obesity, HTN, or DM with postmenopausal bleeding.

54
Q

Treatment of DUB 2/2 acute hemorrage

A
  • IV estrogen (premarin)
  • observation and COC’s
  • refractory = IUD
  • definitive = hysterectomy
55
Q

Treatment of postmenopausal DUB

A

Hormones
US
Hysteroscopy

56
Q

Menopause

A

No period for 12 months

57
Q

What are the stages of menopause

A
  1. climacteric (phase transitioning from reproductive -> non-reproductive)
  2. menopausal transition (phase when menstrual cycle is irregular, lasts 1-3 years.)
  3. menopause (final menstrual cycle occurs)
  4. postmenopause (after menopause)
58
Q

What is considered premature menopause

A

prior to age 40

58
Q

Hormone levels in menopause, consider effects on:
LH, FSH, Inhibin, estrogen, progesterone, androstenedione, sex hormone binding globulin, and testosterone.

A

Low inhibin
Increased FSH and LH
Decreased estrogen (greatest decreased in estradiol!)
Decreased progesterone
decreased androstenedione
decreased testosterone
decreased sex hormone binding globulin

basically everything decreases except LH and FSH. (these rise because there is no negative feedback from estrogen and progesterone)

59
Q

S/S of menopause

A

Hot flashes
Mood swings
Vaginal dryness
Hair loss

60
Q

When does a female have the most oocytes

A

As a fetus at 20 weeks gestation. (7 million)

just fun fact:
7 million at 20 weeks
1-2 million @ birth
300,000-500,000 at puberty

61
Q

Treatment of menopause

A

Vaginal moisturizer
Estrogens

62
Q

Known risks of hormone replacement

A

Endometrial cancer
Breast cancer
Clots

63
Q

1st line tx for vasomotor menopause sx (hot flashes)

A

Transdermal estrogen

64
Q

what if the tx of hot flashes if trasndermal estrogen is CI

A

progestin alone
SSRI or SNRI
black cohosh
gabapentin
clonidine

65
Q

Pros and cons of combination hormone therapy

for menopause

A

Pro: adding progesterone to estrogen decreases risk of endometrial cancer rather than just unopposed estrogen
Con: addition of progesterone to estrogen increases risk of breast cancer

66
Q

If patient has intact uterus ___

(menopause treatment)

A

Must do combo estrogen and progesterone

67
Q

what occurs as a result of atrophic vaginitis

A

loss of lactobacillus which converts glucose to lactic acid leading to an increase in vaginal pH of 5-7

68
Q

what is the first line INITIAL treatment for atrophic vaginitis

A

vaginal moisturizer

69
Q

what is the treatment of moderate/severe atrophic vaginitis if vaginal moisturizer fails.

A

topical vaginal estrogen

70
Q

aside from vaginal moisturizer and vaginal estrogen, what are the other options for tx of atrophic vaginitis

A
  • prasterone suppository (converts androtest and test -> estrone and estradiol. )
  • ospemifene oral (mimics estrogen but causes hot flashes)
  • testosterone 1-2% cream (if estrogen CI)
71
Q

Actions of estrogen

A

Endometrial proliferation
Development of secondary sex characteristics
Increased vaginal lubrication

72
Q

Actions of progesterone

A

Decrease uterine contractility
Promotes breast development
Falling levels trigger menses and lactation

73
Q

Major hormone of pregnancy

A

Progesterone

74
Q

Etiology of pelvic inflammatory disease

A

Polymicrobial

gonorrhea, chlamydia, mycoplasma genintalum

75
Q

S/S of PID

A

Lower abdominal pain
Cervical motion tenderness (chandelier sign)
Fever

76
Q

Treatment of PID

A

Rocephin + Doxy + Flagyl